Simvastatin could become a pharmacy medicine within the next 6 months if a UK proposal to reclassify the drug is approved

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.441, 2003-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generic simvastatin switch could save UK NHS £2 billion

By  

Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Could cloning become permissible?

By Simpson Joe Leigh  

Reproductive BioMedicine Online, Vol. 14, Iss. 1, 2007-02 ,pp. : 125-129

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

The UK MHRA is to reclassify sumatriptan [Imigran Recovery; GlaxoSmithKline]

By  

Inpharma, Vol. 1, Iss. 1540, 2006-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Retail pharmacy drug sales reached $US429 billion in 13 major markets in the 12 months to April 2008

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 558, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pharmacogenetics, the next challenge for pharmacy?

By Clemerson Jessica   Payne Katherine   Bissell Paul   Anderson Claire  

Pharmacy World and Science, Vol. 28, Iss. 3, 2006-06 ,pp. : 126-130

Springer Publishing Company

Access to resources Recommend Favorite